Publicaciones en las que colabora con RAFAEL VÍCTOR ARROYO GONZÁLEZ (19)

2017

  1. Multimarker risk stratification approach at multiple sclerosis onset

    Clinical Immunology, Vol. 181, pp. 43-50

2016

  1. Monitoring the John Cunningham virus throughout natalizumab treatment in multiple sclerosis patients

    European Journal of Neurology, Vol. 23, Núm. 1, pp. 182-189

2014

  1. HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-ß therapy in multiple sclerosis

    Journal of Medical Genetics, Vol. 51, Núm. 6, pp. 395-400

2011

  1. Validation of IRF5 as multiple sclerosis risk gene: Putative role in interferon beta therapy and human herpes virus-6 infection

    Genes and Immunity, Vol. 12, Núm. 1, pp. 40-45

2010

  1. Chromosomal region 16p13: Further evidence of increased predisposition to immune diseases

    Annals of the Rheumatic Diseases, Vol. 69, Núm. 1, pp. 309-311

  2. IFNβ-1a therapy for multiple sclerosis expands regulatory CD8+ T cells and decreases memory CD8+ subset: A longitudinal 1-year study

    Clinical Immunology, Vol. 134, Núm. 2, pp. 148-157

  3. Polymorphisms in the IL2, IL2RA and IL2RB genes in multiple sclerosis risk

    European Journal of Human Genetics, Vol. 18, Núm. 7, pp. 794-799

2009

  1. Clinical response to interferon-β-1a may be linked to low baseline circulating BDCA1 myeloid dendritic cells. Differential role of circulating dendritic cells and CD4+ regulatory T-cells in relapsing-remitting multiple sclerosis: A 1-year longitudinal study

    Journal of Neuroimmunology, Vol. 212, Núm. 1-2, pp. 112-120

  2. Effect of BSN-MST1 locus on inflammatory bowel disease and multiple sclerosis susceptibility

    Genes and Immunity, Vol. 10, Núm. 7, pp. 631-635

2008

  1. Association of the STAT4 gene with increased susceptibility for some immune-mediated diseases

    Arthritis and Rheumatism, Vol. 58, Núm. 9, pp. 2598-2602

  2. IFIH1-GCA-KCNH7 locus: Influence on multiple sclerosis risk

    European Journal of Human Genetics, Vol. 16, Núm. 7, pp. 861-864

2007

  1. FcRL3 and multiple sclerosis pathogenesis: Role in autoimmunity?

    Journal of Neuroimmunology, Vol. 189, Núm. 1-2, pp. 132-136

  2. Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: An ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis

    Journal of Neuroimmunology, Vol. 182, Núm. 1-2, pp. 204-211

2005

  1. Early B-cell factor gene association with multiple sclerosis in the Spanish population

    BMC Neurology, Vol. 5

2004

  1. TNF-376A marks susceptibility to MS in the Spanish population A replication study

    Neurology, Vol. 62, Núm. 5, pp. 809-810

2002

  1. Interleukin-10 polymorphisms in Spanish multiple sclerosis patients

    Journal of Neuroimmunology, Vol. 131, Núm. 1-2, pp. 168-172

1999

  1. Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis

    Neurology, Vol. 53, Núm. 6, pp. 1361-1363

  2. Susceptibility to multiple sclerosis mediated by HLA-DRB1 is influenced by a second gene telomeric of the TNF cluster

    Human Immunology, Vol. 60, Núm. 12, pp. 1266-1273

1997

  1. Combined effect of HLA-DRB1* 1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis

    Journal of Neuroimmunology, Vol. 80, Núm. 1-2, pp. 172-178